272 related articles for article (PubMed ID: 31622280)
1. Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation.
Lorscheid S; Müller A; Löffler J; Resch C; Bucher P; Kurschus FC; Waisman A; Schäkel K; Hailfinger S; Schulze-Osthoff K; Kramer D
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31622280
[TBL] [Abstract][Full Text] [Related]
2. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.
Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457
[TBL] [Abstract][Full Text] [Related]
3. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
[TBL] [Abstract][Full Text] [Related]
4. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ.
Tu J; Yin Z; Guo J; He F; Long F; Yin Z
Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918
[TBL] [Abstract][Full Text] [Related]
5. IκBζ: A key protein in the pathogenesis of psoriasis.
Johansen C
Cytokine; 2016 Feb; 78():20-1. PubMed ID: 26615569
[TBL] [Abstract][Full Text] [Related]
6. IL-17F regulates psoriasis-associated genes through IκBζ.
Bertelsen T; Ljungberg C; Boye Kjellerup R; Iversen L; Johansen C
Exp Dermatol; 2017 Mar; 26(3):234-241. PubMed ID: 27576147
[TBL] [Abstract][Full Text] [Related]
7. IκBζ is a key driver in the development of psoriasis.
Johansen C; Mose M; Ommen P; Bertelsen T; Vinter H; Hailfinger S; Lorscheid S; Schulze-Osthoff K; Iversen L
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):E5825-33. PubMed ID: 26460049
[TBL] [Abstract][Full Text] [Related]
8. PFN1 Prevents Psoriasis Pathogenesis through IκBζ Regulation.
Mok BR; Kim AR; Baek SH; Ahn JH; Seok SH; Shin JU; Kim DH
J Invest Dermatol; 2022 Sep; 142(9):2455-2463.e9. PubMed ID: 35148999
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ.
Hu Y; Guo J; Yin L; Tu J; Yin Z
Inflammation; 2020 Apr; 43(2):692-700. PubMed ID: 31838663
[TBL] [Abstract][Full Text] [Related]
10. miR-378a regulates keratinocyte responsiveness to interleukin-17A in psoriasis.
Xia P; Pasquali L; Gao C; Srivastava A; Khera N; Freisenhausen JC; Luo L; Rosén E; van Lierop A; Homey B; Pivarcsi A; Sonkoly E
Br J Dermatol; 2022 Aug; 187(2):211-222. PubMed ID: 35257359
[TBL] [Abstract][Full Text] [Related]
11. IκBζ is a key player in the antipsoriatic effects of secukinumab.
Bertelsen T; Ljungberg C; Litman T; Huppertz C; Hennze R; Rønholt K; Iversen L; Johansen C
J Allergy Clin Immunol; 2020 Jan; 145(1):379-390. PubMed ID: 31622687
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
Xu X; Prens E; Florencia E; Leenen P; Boon L; Asmawidjaja P; Mus AM; Lubberts E
Front Immunol; 2021; 12():719562. PubMed ID: 34616394
[TBL] [Abstract][Full Text] [Related]
13. Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes.
Zhou Y; Wang P; Chen XY; Yan BX; Landeck L; Wang ZY; Xu F; Zheng M; Man XY
Cell Prolif; 2022 Oct; 55(10):e13290. PubMed ID: 35716036
[TBL] [Abstract][Full Text] [Related]
14. IkBζ is a Key Regulator of Tumour Necrosis Factor-a and Interleukin-17A-mediated Induction of Interleukin-36g in Human Keratinocytes.
Ovesen SK; Schulze-Osthoff K; Iversen L; Johansen C
Acta Derm Venereol; 2021 Feb; 101(2):adv00386. PubMed ID: 33491092
[TBL] [Abstract][Full Text] [Related]
15. The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ.
Bertelsen T; Iversen L; Johansen C
Exp Dermatol; 2018 Sep; 27(9):1048-1052. PubMed ID: 29938836
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
17. EGFR ligands synergistically increase IL-17A-induced expression of psoriasis signature genes in human keratinocytes via IκBζ and Bcl3.
Dai X; Murakami M; Shiraishi K; Muto J; Tohyama M; Mori H; Utsunomiya R; Sayama K
Eur J Immunol; 2022 Jun; 52(6):994-1005. PubMed ID: 35411943
[TBL] [Abstract][Full Text] [Related]
18. Threonine Phosphorylation of IκBζ Mediates Inhibition of Selective Proinflammatory Target Genes.
Grondona P; Bucher P; Schmitt A; Schönfeld C; Streibl B; Müller A; Essmann F; Liberatori S; Mohammed S; Hennig A; Kramer D; Schulze-Osthoff K; Hailfinger S
J Invest Dermatol; 2020 Sep; 140(9):1805-1814.e6. PubMed ID: 32035922
[TBL] [Abstract][Full Text] [Related]
19. T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis.
Cataisson C; Salcedo R; Michalowski AM; Klosterman M; Naik S; Li L; Pan MJ; Sweet A; Chen JQ; Kostecka LG; Karwan M; Smith L; Dai RM; Stewart CA; Lyakh L; Hsieh WT; Khan A; Yang H; Lee M; Trinchieri G; Yuspa SH
Mol Cancer Res; 2019 Aug; 17(8):1759-1773. PubMed ID: 31164412
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation.
Veras FP; Publio GA; Melo BM; Prado DS; Norbiato T; Cecilio NT; Hiroki C; Damasceno LEA; Jung R; Toller-Kawahisa JE; Martins TV; Assunção SF; Lima D; Alves MG; Vieira GV; Tavares LA; Alves-Rezende ALR; Karbach SH; Nakaya HI; Cunha TM; Souza CS; Cunha FQ; Sales KU; Waisman A; Alves-Filho JC
Cell Rep; 2022 Dec; 41(13):111897. PubMed ID: 36577385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
